Patients Say They Want to Switch to Less Frequent Therapies

Patients Say They Want to Switch to Less Frequent Therapies

310274

Patients Say They Want to Switch to Less Frequent Therapies

Patients with hereditary angioedema (HAE) are willing to try new therapies that can effectively lessen disease burden with less frequent dosing, according to an interview-based study conducted by Astria Therapeutics. The findings were shared in a poster, titled “Burdens of Disease and Treatment in Hereditary Angioedema: Interview Insights from HAE Patients,” presented at the virtual 2021 NORD Rare Diseases and Orphan Products Breakthrough Summit, which ran Oct. 18–19. “Our learnings from these findings support that…

You must be logged in to read/download the full post.